Vaccine Treatment for Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00073398 · COMPLETED

Trial details

NCT number: NCT00073398
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Carcinoma Adenocarcinoma of Lung Squamous Cell Carcinoma Large Cell Carcinoma Lung Neoplasms

Start date: 2003-11-01
Primary completion: 2012-11-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.